Maternal Anxiety

2

Review clinical trials related to Maternal Anxiety. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Restrained vs Gripping String Techniques in Patients Undergoing Cesarean Delivery

This randomized controlled trial will compare two upper-extremity restraint techniques in patients undergoing elective cesarean delivery under neuraxial anesthesia. Participants will be randomly assigned to either standard forearm restraint placement or wrist-level gripping restraint placement. The study will evaluate whether the position of the restraint affects maternal anxiety during and after cesarean delivery. Anxiety will be measured at several perioperative time points using the State-Trait Anxiety Inventory (STAI-6). Secondary outcomes include pain, patient satisfaction, physiological measures such as heart rate and blood pressure, postpartum distress and mood, and restraint-related safety events. The study aims to determine whether wrist-level gripping restraints may reduce anxiety and improve the patient experience compared with standard forearm restraints.

Participants needed: 272
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Ohio State UniversityUpdated: Aug 19, 2026Locations: 1
Eligibility criteria

Age ≥18 years to 50 years old [+5]

Not receiving neuraxial anesthesia or not scheduled for cesarean delivery [+6]

Status: Recruiting

Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section

This study aims to compare the efficacy of intravenous dexmedetomidine infusion versus virtual reality (VR) in reducing maternal anxiety, stress, and hemodynamic instability during cesarean section and their effects on neonatal outcome as respiration and heart rate.

Participants needed: 52
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Benha UniversityUpdated: Jan 21, 2026Locations: 1
Eligibility criteria

Age over 18 years old. [+3]

Patient's refusal [+9]